Rchr
J-GLOBAL ID:200901082194284300   Update date: Oct. 21, 2024

ITO TOMOKI

イトウ トモキ | ITO TOMOKI
Affiliation and department:
Job title: Professor
Research field  (2): Allergies and connective tissue disease ,  Immunology
Research theme for competitive and other funds  (10):
  • 2018 - 2020 Functional analysis of OX40 signal in glioma cancer stem cells
  • 2012 - 2015 線溶系物質による樹状細胞機能の制御:炎症性疾患に向けた新たな治療コンセプトの提案
  • 2011 - 2014 血管内皮細胞由来マイクロパーティクルによるDIC病態早期診断法の研究
  • 2011 - 現在 全身性エリテマトーデスにおける樹状細胞機能に及ぼすプロラクチンの作用について
  • 2009 - 2011 Trial to the therapeutic strategy for inflammatory disorders by targeting immunomodulatory molecule OX40 ligand
Show all
Papers (154):
  • Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Aspiration pneumonia after SARS-CoV-2 Omicron infection frequently induced physical functional decline in Japan. Journal of medical microbiology. 2024. 73. 8. 001872
  • Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Ito T. Invalidity of JRS atypical pneumonia prediction score in Omicron variant of COVID-19 pneumonia. Respiratory investigation. 2024. 62. 3. 384-387
  • Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Comparison of pneumonia severity scores for COVID-19 patients with the Omicron variant. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024. 30. 5. 463-466
  • Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Ito T. Is the JRS atypical pneumonia prediction score useful in detecting COVID-19 pneumonia under nursing or healthcare settings?. Respiratory investigation. 2024. 62. 2. 187-191
  • Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Functional decline at 1 year in hospitalized elderly pneumonia with SARS-CoV-2 Omicron variant: Comparison with the ancestral strain and Alpha variant. Influenza and other respiratory viruses. 2024. 18. 2. e13251
more...
MISC (77):
  • Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Efficacy of ensitrelvir for cough due to COVID-19 Omicron variant in medical healthcare workers. Antimicrobial agents and chemotherapy. 2024. 68. 10. e0106424
  • Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ito T. Aspiration pneumonia was the most frequent cause of death in older patients with SARS-CoV-2 omicron-related pneumonia in Japan. Journal of the American Geriatrics Society. 2024. 72. 7. 2234-2236
  • Yuka Ishii, Jun Ichikawa, Masaya Okada, Kazuyoshi Ishii and Tomoki Ito. Successful treatment of Dara sc-CyBorD in a patient with AL amiyloidosis and severe heart failure. International Journal of Myeloma 14(1):5-11,2024. 2024. 14. 1. 5-11
  • Kuwana M, Ito T, Kowata S, Hatta Y, Fujimaki K, Naito K, Kurahashi S, Kagoo T, Tanimoto K, Saotome S, et al. Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study. American journal of hematology. 2024. 99. 2. E55-E59
  • Ishiura Y, Nomura S, Ishii Y, Imai K, Sawai Y, Tamaki T, Shimizu T, Miyashita N, Ito T. Efficacy of Gefapixant, a P2X3 Antagonist, for Refractory Atopic Cough. International medical case reports journal. 2023. 16. 4. 497-501
more...
Books (9):
  • B 細胞リンパ腫に対する BCL-2 阻害薬「血液内科」
    科学評論社 2023
  • プロテアソーム阻害薬「臨床雑誌内科」
    南江堂 2022
  • エロツズマブと血小板減少「Thrombosis Medicine」
    先端医学社 2020
  • 悪性リンパ腫におけるFDG-PETと背景抑制広範囲拡散強調画像(DWIBS)を用いた評価の試み「臨床放射線」
    金原出版 2020
  • 多発性骨髄腫における抗体医薬エロツズマブ・ダラツムマブの作用機序および治療選択「血液内科」
    科学評論社 2020
more...
Lectures and oral presentations  (346):
  • Phase 1/2 Study of the Activin Receptor-like Kinase-2 Inhibitor Zilurgisertib (INCB000928, LIMBER-104) as Monotherapy or With Ruxolitinib in Patients With Anemia due to Myelofibrosis
    (ASH2023 第65回米国血液学会 2023)
  • LONG-TERM TREATMENT WITH FOSTAMATINIB IN JAPANESE PATIENTS WITH PRIMARY ITP
    (ASH2023 第66回米国血液学会 2023)
  • Interim Phase I Safety Study of Anti-Transferrin Receptor Antibody(PPMX-T003) in Patients with Polycythemia Vera
    (ASH2023 第65回米国血液学会 2023)
  • Thrombotic and bleeding events in Japanese Adolescent and Young Adult PV and ET - Results from Japanese multicenter retrospective study -
    (ASH2023 第65回米国血液学会 2023)
  • Efficacy and Safety of Polatuzumab-Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) for Diffuse Large B-Cell Lymphoma in the Real-World Setting: A Single Institute Retrospective Study
    (65th American Society of Hematology Annual Meeting and Exposition 2023)
more...
Work history (1):
  • 2007/04 - 2011/04 Kansai Medical University Faculty of Medicine Lecturer
Committee career (5):
  • 2000 - 現在 日本リンパ網内系学会 評議員
  • 1994 - 現在 日本リンパ網内系学会 将来構想委員
  • 日本臨床血液学会 代議員
  • 日本免疫学会 評議員
  • 日本血液学会 代議員
Awards (1):
  • 1999 - 第39回日本リンパ網内系学会総会学会奨励賞(臨床部門)
Association Membership(s) (5):
日本リウマチ学会 ,  日本免疫学会 ,  日本臨床血液学会 ,  日本リンパ網内系学会 ,  日本血液学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page